MSN-Res inhibited breast cancer progression with improved efficacy than Res treatment alone by inhibiting the NF-κB signaling pathway, suggesting that MSN-Res is a more effective adjuvant treatment method for breast cancer, which provides a new and safer means of using phytochemicals in combinatorial therapy of breast cancer. This evidence concerns the gene NFKB1 and breast carcinoma.